UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Comparison of quantitative ultrasonography and dual X-ray absorptiometry for bone status assessment in South African children living with HIV

PloS one, 2022-10, Vol.17 (10), p.e0276290-e0276290

2022

Volltextzugriff (PDF)

Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children

PloS one, 2018-04, Vol.13 (4), p.e0195514-e0195514

2018

Volltextzugriff (PDF)

High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa

International journal of infectious diseases, 2022-12, Vol.125, p.241-249

2022

Volltextzugriff (PDF)

Initiation of Antiretroviral Therapy Before 6 Months of Age is Associated with Faster Growth Recovery in South African Children Perinatally Infected with Human Immunodeficiency Virus

The Journal of pediatrics, 2013-06, Vol.162 (6), p.1138-1145.e2

2013

Volltextzugriff (PDF)

Decreased Vigorous Physical Activity in School-Aged Children with Human Immunodeficiency Virus in Johannesburg, South Africa

The Journal of pediatrics, 2016-05, Vol.172, p.103-109

2016

Volltextzugriff (PDF)

Early antiretroviral treatment of infants to attain HIV remission

EClinicalMedicine, 2020-01, Vol.18, p.100241-100241, Article 100241

2020

Volltextzugriff (PDF)

Dietary Inadequacies in HIV‐infected and Uninfected School‐aged Children in Johannesburg, South Africa

Journal of pediatric gastroenterology and nutrition, 2017-09, Vol.65 (3), p.332-337

2017

Volltextzugriff (PDF)

Safety surveillance for PrEP in pregnant and breastfeeding women

Frontiers in reproductive health, 2023-09, Vol.5, p.1221101-1221101

2023

Volltextzugriff (PDF)

Virologic Response to Very Early HIV Treatment in Neonates

Journal of clinical medicine, 2021-05, Vol.10 (10), p.2074

2021

Volltextzugriff (PDF)

HIV treatment success in children and adolescents with HIV

The lancet HIV, 2022-08, Vol.9 (8), p.e526-e527

2022

Volltextzugriff (PDF)

Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study

Journal of the Pediatric Infectious Diseases Society, 2018-05, Vol.7 (2), p.143-150

2018

Volltextzugriff (PDF)

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

The New England journal of medicine, 2021-05, Vol.384 (20), p.1885-1898

2021

Volltextzugriff (PDF)

6 Epigenetic dysregulation of the major histocompatibility complex (MHC) region in HIV-infected children on early antiretroviral therapy

Journal of Virus Eradication, 2017-07, Vol.3, p.7-8

2017

Volltextzugriff (PDF)

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet (British edition), 2022-03, Vol.399 (10330), p.1141-1153

2022

Volltextzugriff (PDF)

Growth Trajectories Over the First Year of Life Among Early-Treated Infants with Human Immunodeficiency Virus and Infants Who are Human Immunodeficiency Virus-Exposed Uninfected

The Journal of pediatrics, 2024-07, Vol.270, p.114018, Article 114018

2024

Volltextzugriff (PDF)

Microbiota in the oral cavity of school-age children living with HIV who started antiretroviral therapy at young ages in South Africa

AIDS (London), 2023-05, Vol.37 (10), p.1583-1591

2023

Volltextzugriff (PDF)

Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2015-11, Vol.314 (17), p.1808

2015

Volltextzugriff (PDF)

Persistently lower bone mass and bone turnover among South African children living with well controlled HIV

AIDS (London), 2021-11, Vol.35 (13), p.2137-2147

2021

Volltextzugriff (PDF)

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial

The lancet HIV, 2021-09, Vol.8 (9), p.e568-e580

2021

Volltextzugriff (PDF)

Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial

Clinical infectious diseases, 2017-08, Vol.65 (3), p.477-485

2017

Volltextzugriff (PDF)

Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants

Clinical infectious diseases, 2022-03, Vol.74 (6), p.1047-1054

2022

Volltextzugriff (PDF)

Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa

AIDS (London), 2023-08, Vol.37 (10), p.1583-1591

2023

Volltextzugriff (PDF)

Disclosure to South African children about their own HIV status over time

AIDS care, 2023-03, Vol.35 (3), p.334-340

2023

Volltextzugriff (PDF)

Negative Diagnostic PCR Tests in School-Aged, HIV-Infected Children on Antiretroviral Therapy Since Early Life in Johannesburg, South Africa

Journal of acquired immune deficiency syndromes (1999), 2020-04, Vol.83 (4), p.381

2020

Volltextzugriff (PDF)

Switch to Efavirenz Attenuates Lipoatrophy in Girls With Perinatal HIV

Journal of pediatric gastroenterology and nutrition, 2021-01, Vol.72 (1), p.e15-e20

2021

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(61)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparison of quantitative ultrasonography and dual X-ray absorptiometry for bone status assessment in South African children living with HIV

Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children

High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa

Initiation of Antiretroviral Therapy Before 6 Months of Age is Associated with Faster Growth Recovery in South African Children Perinatally Infected with Human Immunodeficiency Virus

Decreased Vigorous Physical Activity in School-Aged Children with Human Immunodeficiency Virus in Johannesburg, South Africa

Early antiretroviral treatment of infants to attain HIV remission

Dietary Inadequacies in HIV‐infected and Uninfected School‐aged Children in Johannesburg, South Africa

Safety surveillance for PrEP in pregnant and breastfeeding women

Virologic Response to Very Early HIV Treatment in Neonates

HIV treatment success in children and adolescents with HIV

Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

6 Epigenetic dysregulation of the major histocompatibility complex (MHC) region in HIV-infected children on early antiretroviral therapy

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

Growth Trajectories Over the First Year of Life Among Early-Treated Infants with Human Immunodeficiency Virus and Infants Who are Human Immunodeficiency Virus-Exposed Uninfected

Microbiota in the oral cavity of school-age children living with HIV who started antiretroviral therapy at young ages in South Africa

Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial

Persistently lower bone mass and bone turnover among South African children living with well controlled HIV

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial

Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial

Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants

Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa

Disclosure to South African children about their own HIV status over time

Negative Diagnostic PCR Tests in School-Aged, HIV-Infected Children on Antiretroviral Therapy Since Early Life in Johannesburg, South Africa

Switch to Efavirenz Attenuates Lipoatrophy in Girls With Perinatal HIV

Suchergebnisse filtern